Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05548465Completed
Randomised trial of remifentanil in pain (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Postoperative numerical rating scales at rest at 48 hours. Started Sep 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05548465.